i.v. iron sucrose — Competitive Intelligence Brief

i.v. iron sucrose (i.v. iron sucrose) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement agent. Area: Hematology.

marketed Iron replacement agent Hematology Small molecule

Target snapshot

i.v. iron sucrose (i.v. iron sucrose) — J. Uriach and Company. Iron sucrose is a stable iron-carbohydrate complex that delivers iron directly into the bloodstream to replenish depleted iron stores and support hemoglobin synthesis.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
i.v. iron sucrose TARGET	i.v. iron sucrose	J. Uriach and Company	marketed	Iron replacement agent
SFP	SFP	Rockwell Medical Technologies, Inc.	marketed	Intravenous iron replacement agent	Iron (Fe3+) for hemoglobin synthesis and erythropoiesis
Ferric Carboxymaltose (FCM)	Ferric Carboxymaltose (FCM)	American Regent, Inc.	marketed	Intravenous iron replacement agent	Iron (Fe³⁺) delivery; transferrin and ferritin binding
ferric(III)carboxymaltose	ferric(III)carboxymaltose	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	marketed	Iron replacement agent	Iron metabolism / transferrin-mediated iron transport
Triferic AVNU	Triferic AVNU	Rockwell Medical Technologies, Inc.	marketed	Iron replacement agent	Iron (Fe3+) delivery system
Iron Carboxymaltose	Iron Carboxymaltose	Albina Nowak, MD	marketed	Intravenous iron replacement agent	Iron(III) ion; transferrin and ferritin (iron-binding proteins)
Aggressive iron dextran supplementation	Aggressive iron dextran supplementation	Shanghai East Hospital	marketed	Iron replacement agent	Iron (Fe3+) for hemoglobin and myoglobin synthesis

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement agent class)

1. University of Maryland, Baltimore · 2 drugs in this class
2. Ain Shams University · 1 drug in this class
3. American Regent, Inc. · 1 drug in this class
4. Azad Pharma AG · 1 drug in this class
5. CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
6. China-Japan Friendship Hospital · 1 drug in this class
7. Hallym University Medical Center · 1 drug in this class
8. J. Uriach and Company · 1 drug in this class
9. JW Pharmaceutical · 1 drug in this class
10. Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class